The order Flavobacteriales: ecological features and clinical signifi-cance in the development of human pathology: review

Article Sidebar

pdf (Русский)
Published: Mar 29, 2023
DOI: https://doi.org/10.17072/1994-9952-2023-1-58-64
Keywords:
Flavobacteriales morphology biochemical properties conditionally pathogenic microorganisms nosocomial infections

Main Article Content

Ksenia V. Zubova
Saratov National Research State University named after N.G. Chernyshevsky, Saratov, Russia
https://orcid.org/0000-0002-9406-080X

Abstract

The article presents an overview of some representatives of the order Flavobacteriales, in particular clinically significant members of the family Weeksellaceae. Morphological, cultural, and biochemical properties of species important for medicine and biology, namely Chryseobacterium, Elizabethkingia, and Empedobacter, are described. Several physiological features are highlighted. Some data on the phylogeny of these organisms are given. Ecological characteristics are considered, and information about some pathogenic species for humans and animals is presented. Also, literature data on resistance to currently available antimicrobial drugs are given. Clinical cases of infections with bacteria of the genera Chryseobacterium, Elizabethkingia, and Empedobacter, features of the diseases caused, and data on the frequency of infections with these microorganisms are reported. Based on the analyzed data, it has been revealed that species belonging to the order Flavobacteriales may pose a risk to immunocompromised people, to patients with chronic diseases such as cystic fibrosis and oncology, and to infants and the elderly. It has been established that representatives of the order cause nosocomial infections. It has been also found that clinically significant species have intrinsic resistance to a wide range of antimicrobials, and therefore the selection of etiotropic therapy is difficult.

Article Details

How to Cite
Zubova К. В. (2023). The order Flavobacteriales: ecological features and clinical signifi-cance in the development of human pathology: review. Bulletin of Perm University. Biology, (1), 58–64. https://doi.org/10.17072/1994-9952-2023-1-58-64
Issue
No. 1 (2023): Bulletin of Perm University. BIOLOGY
Section
Микробиология

License agreement

 

Author Biography

Ksenia V. Zubova, Saratov National Research State University named after N.G. Chernyshevsky, Saratov, Russia

Postgraduate student of the Department of Microbiology and Plant Physiology

References

Боронина Л.Г. и др. Род Chryseobacterium (Flavobacterium): клиническое значение, идентификация, чувствительность к антибиотикам // Клиническая микробиология и антимикробная химиотерапия. 2003. Т. 5, № 3. С. 243–250. URL: https://cmac-journal.ru/publication/2003/3/cmac-2003-t05-n3-p243/

Зубова К.В. и др. Видовой состав представителей порядка Flavobacteriales, выделенных от пациентов с муковисцидозом в Российской Федерации за 2019−2021 гг. // Проблемы медицинской микологии. 2022. Т. 24, № 2. С. 74–75.

Abdalhamid B. et al. Chryseobacterium gleum pneumonia in an infant with nephritic syndrome // IDCas-es. 2016. Vol. 5. P. 34–36. DOI: 10.1016/j.idcr.2016.06.004

Garg S. et al. Pyonephrosis dueto Chryseobacterium gleum: a first case report // Indian Journal of Medical Microbiology. 2015. Vol. 2, № 33. P. 311–313. DOI: 10.4103/0255-0857.154894

Carvalho F.É.B., Marson A.L., Levy C.E. Challenges in the identification of Chryseobacterium indologenes and Elizabethkingia meningoseptica in cases of nosocomial infections and patients with cystic fibrosis // New Microbes and New Infections. 2017. Vol. 20. P. 27–33. DOI: 10.1016/j.nmni.2017.09.002

Guiu A. et al. Chryseobacterium spp., a new opportunistic pathogen associated with cystic fibrosis? // Enfermedades Infecciosas Microbiologìa Clìnica. 2014. Vol. 32, № 8. P. 497–501. DOI: 10.1016/j.eimc.2013.08.003

Hsueh P.R. et al. Flavobacterium indologenes bacteremia: clinical and microbiological characteristics // Clinical Infectious Diseases. 1996. Vol. 23, № 3. P. 550–555. DOI: 10.1093/clinids/23.3.550

Izaguirre-Anariba D.E., Sivapalan V. Chryseobacterium indologenes, an emerging bacteria: A case report and review of literature // Cureus. 2020. Vol. 12, № 1. Article e6720. DOI: 10.7759/cureus.6720

Janda J.M., Lopez-Denise L. Mini review: New pathogen profiles: Elizabethkingia anopheles // Diagnostic Microbiology and Infectious Disease. 2017. Vol. 88. P. 201–205. DOI: 10.1016/j.diagmicrobio.2017.03.007

Jean S.S. et al. Elizabethkingia meningoseptica: an important emerging pathogen causing healthcare-associated infections // Journal of Hospital Infection. 2014. Vol. 86, № 4. P. 244–249. DOI: 10.1016/j.jhin.2014.01.009

Kamran Z. et al. Empedobacter falsenii: a rare non-fermenter causing urinary tract infection in a child with bladder cancer // SOA: Clinical Medical Cases, Reports & Reviews. 2017. Vol. 1, № 1. P. 1–3. DOI: 10.12998/wjcc.v5.i5.187

Kenna D.T.D. et al. rpoB gene sequencing highlights the prevalence of an E. miricola cluster over other Elizabethkingia species among UK cystic fibrosis patients // Diagnostic Microbiology and Infectious Disease. 2018. Vol. 90. P. 109–114. DOI: 10.1016/j.diagmicrobio.2017.10.014

Kim K.K. et al. Transfer of Chryseobacterium meningosepticum and Chryseobacterium miricola to Eliz-abethkingia gen. nov. as Elizabethkingia meningoseptica comb. nov. and Elizabethkingia miricola comb. nov. // International Journal of Systematic and Evolution Microbiology. 2005. Vol. 55. P. 1287–1293. DOI: 10.1099/ijs.0.63541-0

Lin Y.-T. et al. Tigecycline and colistin susceptibility of Chryseobacterium meningosepticum isolated from blood in Taiwan // International Journal of Antimicrobial Agents. 2009. Vol. 34, № 1. P. 100–101. DOI: 10.1016/j.ijantimicag.2009.01.011

Marchandin H., Michon A.L., Jumas-Bilak E. Atypical Bacteria in the CF Airways // Diversity, Clinical Consequences, Emergence and Adaptation. 2012. URL: https://www.researchgate.net/publication/224829099. DOI: 10.5772/30253

McBride M.J. The family Flavobacteriaceae // The Prokaryotes. 2014. P. 643–667. DOI: 10.1007/978-3-642-38954-2_130

Mirza H.C. et al. Clinical strains of Chryseobacterium and Elizabethkingia spp. isolated from pediatric patients in a university hospital: Performance of MALDI-TOF MS-based identification, antimicrobial suscepti-bilities, and baseline patient characteristics // Microbial Drug Resistance. 2018. Vol. 24, № 6. P. 816–821. DOI: 10.1089/mdr.2017.0206

Pereira G.H. et al. Nosocomial infections caused by Elizabethkingia meningoseptica: An emergent path-ogen // The Brazilian Journal of Infectious Diseases. 2013. Vol. 17, № 5. P. 606–609. DOI: 10.1016/j.bjid.2013.02.011

Pickett M.J. Methods for identification of flavobacteria // Journal of Clinical Microbiology. 1989. Vol. 27. P. 2309–2315. DOI: 10.1128/jcm.27.10.2309-2315.1989.

Sharma D. et al. Empedobacter brevis meningitis in a neonate: A very rare case of neonatal meningitis and literature review // Case Reports in Pediatrics. 2016. Vol. 5. P. 1–4. DOI: 10.1155/2016/7609602

Snesrud E., McGann P., Walsh E. Clinical and genomic features of the first cases of Elizabethkingia anopheles infection in New York, including the first case in a healthy infant without previous nosocomial expo-sure // Journal of the Pediatric Infectious Diseases Society. 2019. Vol. 8, № 3. P. 269–271. DOI: 10.1093/jpids/piy071

Tural D.A. et al. Clinical characteristics of children with cystic fibrosis infected with unusual bacteria // Minerva Pediatr (Torino). 2021. Apr. 15. P. 111–114. DOI: 10.23736/S2724-5276.21.06189-2

Van der Velden et al. First report of a Wautersiella falsenii isolated from the urine of an infant with pye-lonephritis // Diagnostic Microbiology and Infectious Disease. 2012. Vol. 4, № 74. P. 404–405. DOI: 10.1016/j.diagmicrobio.2012.08.008